-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Assumes Pfizer at Neutral, Announces Price Target of $25

Benzinga·01/07/2026 13:45:26
语音播报
UBS analyst Michael Yee assumes Pfizer (NYSE:PFE) with a Neutral rating and announces Price Target of $25.